13D Filing: QVT Financial and Arbutus Biopharma Corp (ABUS)
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-l(e), 240....
Posts Tagged ‘QVT Financial’
QVT Financial’s Investments, Performance, Letters
Daniel Gold, who holds a Bachelor of Arts degree in Physics from Harvard College, founded QVT Financial in 2004 after having worked for several years as a star trader at Deutsche...
Axovant Sciences Ltd.(AXON): QVT Financial Acquires Dispositive Power Over 75 Million Shares
Daniel Gold's QVT Financial recently filed a Form 13D with the Securities and Exchanges in which it reported the appointment of its affiliate, Dr.
13G Filing: QVT Financial and pdvWireless, Inc. (PDVW)
Daniel Gold's QVT Financial has recently disclosed its stake in pdvWireless Inc (NASDAQ:PDVW) via a 13G filing with the US Securities and Exchange Commission.
How QVT Financial Gained from Lumber Liquidators Holdings Inc (LL)’s 53% Drop in Q1
As a new filing with the Securities and Exchange Commission shows, Daniel Gold's QVT Financial has initiated a passive stake in Aehr Test Systems (NASDAQ:AEHR).
Tekmira Pharmaceuticals Corp (TKMR): QVT Financial’s New Holding and Two Other Healthcare Picks
Daniel Gold’s QVT Financial has disclosed a new stake in Tekmira Pharmaceuticals Corp (NASDAQ:TKMR). According to the 13D Form filed with the U.S.
Tiger Global Management Reduces Its MakeMyTrip Limited (MMYT) Stake
Tiger Global Management LLC, managed by Chase Coleman, has further reduced its passive stake in MakeMyTrip Limited (NASDAQ:MMYT). In a new filing with the U.S.
Mirati Therapeutics Inc. (MRTX): Baker Bros. Advisors Increases Stake in Growing Stock
Julian Baker and Felix Baker’s Baker Bros. Advisors recently disclosed an increase of around 929,700 shares to its position in Mirati Therapeutics, Inc. (NASDAQ:MRTX).
Zeltiq Aesthetics Inc (ZLTQ), Five Prime Therapeutics Inc (FPRX): Point72’s Latest Bullish Moves
Steve Cohen’s Point72 Asset Management has made bullish moves into a pair of medical technology stocks.
Arrowhead Research Corp (ARWR): Bridger Management Builds 5.5% Passive Stake
Roberto Mignone’s Bridger Management has amassed a 5.5% stake in Arrowhead Research Corp (NASDAQ:ARWR) according to a 13G filing with the Securities and Exchange Commission ...
Agenus Inc (AGEN): QVT Financial Trims Its Passive Stake as It Gains Value
Daniel Gold's QVT Financial has reduced its stake in Agenus Inc (NASDAQ:AGEN) by around 2.34 million shares, as a filing with the Securities and Exchange Commission showed.
Hedge Fund News: Leon Cooperman, Phil Falcone & Sandell Asset Management
Omega Advisors founder Leon Cooperman is having a rough year so far. However, the ex-Goldman Sachs Group, Inc. (NYSE:GS) partner is still bullish on stocks.
Bolt Technology Corp (BOLT), Medical Action Industries (MDCI), Sevcon Inc (SEV) And Peregrine Semiconductor Corp (PSMI) Are Among Mario Gabelli’s Latest Moves
Mario Gabelli is still bullish on Bolt Technology Corp. (NASDAQ:BOLT) and has further increased his fund's holding of the stock.
CONN’S Inc. (CONN): Christian Leone’s Luxor Capital Goes Activist as it Continues to Buy Stock (1.95 Million Shares on Monday)
As reported yesterday, Christian Leone’s Luxor Capital Group has been boosting its exposure to CONN’S, Inc. (NASDAQ:CONN) for quite some time.
Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter Kolchinsky’s Latest Equity Moves
RA Capital Management has continued the sale of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares.
Achillion Pharmaceuticals, Inc. (ACHN): RA Capital Management Sells Over 2 Million Shares
RA Capital Management, managed by Peter Kolchinsky, continues to unload its stake in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In a new filing with the U.S.
Achillion Pharmaceuticals, Inc. (ACHN): Peter Kolchinsky’s RA Capital Sells Some More Shares
Peter Kolchinsky's RA Capital Management, in a new filing with the Securities and Exchange Commission, has disclosed the sale of around 1.70 million shares of Achillion Pharmaceuticals...
Achillion Pharmaceuticals Inc. (ACHN): RA Capital Management Cuts Stake To 19.0% From 21.1%
RA Capital Management, led by Peter Kolchinsky, disclosed in a newly amended filing with the U.S.
RA Capital Management Sells 800,000 Shares of Achillion Pharmaceuticals Inc. (ACHN)
RA Capital Management, managed by Peter Kolchinsky, has sold 800,000 shares of Achillion Pharmaceuticals Inc.
Daniel Gold, QVT Financial Increase Stake In CytRx Corporation (CYTR) & Further Reduce Exposure To Pacific Alliance China Land Limited (PACL)
Daniel Gold, the manager of QVT Financial, is bullish on CytRx Corporation (NASDAQ:CYTR).
Dan Gold’s QVT Financial Reduces Stake in LSE-listed Pacific Alliance China Land Limited (PACL)
A new filing revealed Daniel Gold's QVT Financial reducing its position in London Stock Exchange's AIM-listed company Pacific Alliance China Land Limited (LON:PACL).
QVT Financial Raises Its Stake in China Zenix Auto International Ltd (ZX)
According to a new filing with the Securities and Exchange Commission, Daniel Gold’s fund, QVT Financial, boosted its stake in China Zenix Auto International Ltd (NYSE:ZX), ...
Tang Capital Management Is Getting Out of OncoGenex Pharmaceuticals Inc (OGXI) and Cyclacel Pharmaceuticals Inc (CYCC)
Kevin C. Tang's Tang Capital Management has decreased its position it two pharmaceutical companies.
Glenview Capital Further Increases Position in Tenet Healthcare Corp (THC)
Larry Robbins' hedge fund Glenview Capital has increased its position in Tenet Healthcare Corp (NYSE:THC).
QVT Financial is Bullish on China Zenix Auto International Ltd (ZX); Boosts the Stake to 6.7%
Daniel Gold's QVT Financial has significantly increased its stake in China Zenix Auto International Ltd (NYSE:ZX).
Claren Road Asset Management, QVT Financial Initiate Stakes in DHT Holdings Inc (DHT)
A new filing with the Securities and Exchange Commission showed that Claren Road Asset Management initiated a position in DHT Holdings Inc (NYSE:DHT).
Peter Kolchinsky, Ra Capital Management Inrease Stake in Achillion Pharmaceuticals Again
Peter Kolchinsky's hedge fund, Ra Capital Management disclosed upping its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) some more.
Peter Kolchinsky’s RA Capital Has Been Very Active This Month
Since the beginning of November, Peter Kolchinsky's RA Capital Management has informed the U.S.
Dan Gold’s QVT Ups Stake in Oncothyreon to 5.8%
QVT Financial, a fund managed by Daniel Gold, in a newly amended filing, reported increasing its position in Oncothyreon Inc (USA) (NASDAQ:ONTY) to almost 6.6%, from 5.8% disclosed...
Daniel Gold’s Hedge Fund is 3rd in a Week to Buy Arrowhead Research Stock
Daniel Gold, Arrowhead Research: In a filing with the Securities and Exchange Commission, Daniel Gold's QVT Financial reported ownership of some 2.05 million shares of Arrowhead...
A Verastem Board Member Bought in at $11.53
Verastem, board member: On Monday October 7th, Richard Aldrich, a member of the Board of Directors at Verastem Inc (NASDAQ:VSTM), purchased 1,000 shares of common stock at a ...
How One Anacor Pharmaceuticals Insider is Making Bank
Anacor Pharmaceuticals, Geoffrey Parker: In a recent Form 4 filing with the SEC, M.
Peter Kolchinsky’s Biotech Fund Doubles Achillion Pharmaceuticals Position
RA Capital, Achillion Pharmaceuticals: In a 13G filing with the SEC, Peter Kolchinsky's RA Capital disclosed that it owns nearly 15% of infectious disease-focused biopharma player...
Dan Gold’s Hedge Fund Adds Oncothyreon
Dan Gold's hedge fund: Oncothyreon Inc (USA) (NASDAQ:ONTY) was just added to the equity portfolio of Daniel Gold's hedge fund QVT Financial.
Should You Buy Optimer Pharmaceuticals, Inc. (OPTR)?
At the moment, there are plenty of metrics investors can use to track their holdings. Two of the most under-the-radar are hedge fund and insider trading interest.
Is National Retail Properties, Inc. (NNN) Going to Burn These Hedge Funds?
In the 21st century investor’s toolkit, there are dozens of gauges market participants can use to track stocks.
Dyax Corp. (DYAX): Are Hedge Funds Right About This Stock?
Now, according to many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten age.
Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?
Now, according to many investors, hedge funds are seen as delayed, outdated financial tools of an era lost to time.
Repros Therapeutics Inc (RPRX): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
To many of your peers, hedge funds are viewed as bloated, outdated financial vehicles of a forgotten age.
InterMune Inc (ITMN): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
To many market players, hedge funds are perceived as delayed, old financial tools of a period lost to current times.
Hedge Funds Are Crazy About Green Dot Corporation (GDOT)
In the financial world, there are plenty of metrics shareholders can use to monitor the equity markets.
Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?
To the average investor, there are dozens of indicators market participants can use to analyze their holdings.
Array Biopharma Inc (ARRY): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most innovative are hedge fund and insider trading sentiment.
Hedge Funds Are Crazy About Legg Mason, Inc. (LM)
In the financial world, there are tons of methods market participants can use to watch publicly traded companies.
What Hedge Funds Think About Pharmacyclics, Inc. (PCYC)
In today’s marketplace, there are many metrics market participants can use to track publicly traded companies.
Hedge Funds Are Selling Rowan Companies PLC (RDC)
In today’s marketplace, there are a multitude of gauges shareholders can use to monitor their holdings.
Here is What Hedge Funds Think About DST Systems, Inc. (DST)
In today’s marketplace, there are a multitude of methods shareholders can use to watch publicly traded companies.
What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading activity.
